31115485|t|Alteration of the Wnt/GSK3beta/beta-catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model.
31115485|a|The abnormal activation of glycogen synthase kinase 3beta (GSK3beta) is one of the mechanisms involved in the pathogenesis of Alzheimer's disease (AD), which results in amyloid beta-peptide (Abeta) plaque overproduction, Tau hyperphosphorylation and neuronal loss. A number of studies have reported that the activation of the mammalian target of rapamycin (mTOR) contributes to the generation and deposition of Abeta, as well as to the formation of neurofibrillary tangles (NFTs) by inhibiting autophagy. GSK3beta is also involved in the mTOR signalling pathway. However, whether the inhibition of the activation of mTOR via the regulation of the function of GSK3beta affects the pathology of AD remains unclear. In this study, we intraperitoneally injected amyloid precursor protein (APP)/presenilin-1 (PS1) transgenic mice with rapamycin, a known activator of autophagy that inhibits mTOR. Our results revealed that rapamycin treatment decreased senile plaque deposition by reducing APP generation, and downregulating beta- and gamma-secretase activity. Rapamycin also increased Abeta clearance by promoting autophagy and reduced Tau hyperphosphorylation by upregulating the levels of insulin-degrading enzyme. Additionally, rapamycin markedly promoted the proliferation of differentiated SH-SY5Y cells stably transfected with the APPswe gene and prevented neuronal loss in the brains of mice in a model of AD. Moreover, rapamycin induced autophagy and promoted autolysosome degradation. In this study, we provide evidence that rapamycin inhibits GSK3beta activation and elevates beta-catenin expression by improving the Wnt3a expression levels, which facilitates the amelioration of AD pathology. On the whole, our findings indicate that rapamycin inhibits the activation of mTOR and alters the Wnt/GSK3beta/beta-catenin signalling pathway; thus, it may serve as a therapeutic target in the treatment of AD.
31115485	22	30	GSK3beta	Gene	56637
31115485	31	43	beta-catenin	Gene	12387
31115485	66	75	rapamycin	Chemical	MESH:D020123
31115485	104	123	Alzheimer's disease	Disease	MESH:D000544
31115485	158	188	glycogen synthase kinase 3beta	Gene	56637
31115485	190	198	GSK3beta	Gene	56637
31115485	257	276	Alzheimer's disease	Disease	MESH:D000544
31115485	278	280	AD	Disease	MESH:D000544
31115485	322	327	Abeta	Gene	11820
31115485	381	394	neuronal loss	Disease	MESH:D009410
31115485	457	486	mammalian target of rapamycin	Gene	56717
31115485	488	492	mTOR	Gene	56717
31115485	542	547	Abeta	Gene	11820
31115485	580	603	neurofibrillary tangles	Disease	MESH:D055956
31115485	605	609	NFTs	Disease	MESH:D055956
31115485	636	644	GSK3beta	Gene	56637
31115485	669	673	mTOR	Gene	56717
31115485	747	751	mTOR	Gene	56717
31115485	790	798	GSK3beta	Gene	56637
31115485	824	826	AD	Disease	MESH:D000544
31115485	889	914	amyloid precursor protein	Gene	11820
31115485	921	933	presenilin-1	Gene	19164
31115485	935	938	PS1	Gene	19164
31115485	951	955	mice	Species	10090
31115485	961	970	rapamycin	Chemical	MESH:D020123
31115485	1017	1021	mTOR	Gene	56717
31115485	1049	1058	rapamycin	Chemical	MESH:D020123
31115485	1187	1196	Rapamycin	Chemical	MESH:D020123
31115485	1212	1217	Abeta	Gene	11820
31115485	1318	1342	insulin-degrading enzyme	Gene	3416
31115485	1358	1367	rapamycin	Chemical	MESH:D020123
31115485	1422	1429	SH-SY5Y	CellLine	CVCL:0019
31115485	1490	1503	neuronal loss	Disease	MESH:D009410
31115485	1521	1525	mice	Species	10090
31115485	1540	1542	AD	Disease	MESH:D000544
31115485	1554	1563	rapamycin	Chemical	MESH:D020123
31115485	1661	1670	rapamycin	Chemical	MESH:D020123
31115485	1680	1688	GSK3beta	Gene	56637
31115485	1713	1725	beta-catenin	Gene	12387
31115485	1754	1759	Wnt3a	Gene	22416
31115485	1817	1819	AD	Disease	MESH:D000544
31115485	1872	1881	rapamycin	Chemical	MESH:D020123
31115485	1909	1913	mTOR	Gene	56717
31115485	1933	1941	GSK3beta	Gene	56637
31115485	1942	1954	beta-catenin	Gene	12387
31115485	2038	2040	AD	Disease	MESH:D000544
31115485	Association	MESH:D000544	56637
31115485	Association	11820	56717
31115485	Association	12387	56637
31115485	Positive_Correlation	MESH:D020123	12387
31115485	Association	MESH:D000544	22416
31115485	Negative_Correlation	MESH:D020123	56637
31115485	Association	MESH:D055956	56717
31115485	Negative_Correlation	MESH:D020123	MESH:D000544
31115485	Association	MESH:D009410	56637
31115485	Positive_Correlation	MESH:D020123	3416
31115485	Association	11820	56637
31115485	Negative_Correlation	MESH:D020123	11820
31115485	Association	MESH:D000544	11820
31115485	Association	MESH:D000544	12387
31115485	Negative_Correlation	MESH:D020123	56717
31115485	Association	56637	56717
31115485	Association	11820	3416
31115485	Negative_Correlation	MESH:D020123	MESH:D009410
31115485	Positive_Correlation	MESH:D020123	22416

